Quarterly report [Sections 13 or 15(d)]

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net increase in net assets from operations $ 841,447 $ 1,399,381
Adjustments to reconcile net increase in net assets to net cash provided by (used in) operating activities:    
Investments in portfolio companies (375,000) (10,837,878)
Proceeds from sale of portfolio investments 955,357 3,503,186
Proceeds from loan repayments 8,369,876 2,581,906
Net realized gain on sales and dispositions of portfolio investments (925,332) (3,450,092)
Change in unrealized appreciation/depreciation on investments 1,298,384 2,890,296
Deferred income tax benefit (2,725) (26,636)
Amortization 6,250 6,250
Original issue discount amortization (23,502) (7,002)
Non-cash conversion of debenture interest (624,105) (328,829)
Non-cash conversion of loan modification fee (15,000)  
Change in interest receivable allowance 25,337  
Changes in operating assets and liabilities:    
Decrease (increase) in interest receivable 108,920 (103,155)
Increase in other assets (54,121) (70,797)
Increase in prepaid income taxes (9,872) (26,535)
(Decrease) increase in accounts payable and accrued expenses (46,892) 126,570
Decrease in due to investment adviser (1,637,008) (676,817)
(Decrease) increase in capital gains incentive fees payable (75,000) 112,300
(Decrease) increase in deferred revenue (87,778) 66,969
Total adjustments 6,887,789 (6,240,264)
Net cash provided by (used in) operating activities 7,729,236 (4,840,883)
Cash flows from financing activities:    
Net (repayment of) proceeds from line of credit (600,000) 2,950,000
Payment of cash dividend (3,030,772) (645,255)
Net cash (used in) provided by financing activities (3,630,772) 2,304,745
Net increase (decrease) in cash 4,098,464 (2,536,138)
Cash:    
Beginning of period 834,805 3,295,321
End of period $ 4,933,269 $ 759,183